IQURE PHARMA
iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics.
IQURE PHARMA
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.iqurepharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
750 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Google Cloud Sectigo SSL
Similar Organizations
IASO Pharma
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases.
Wintermute Biomedical Inc
Wintermute Biomedical is a global biopharmaceutical company that develops next-generation antibiotics.
Current Employees Featured
Investors List
Keiretsu Forum Mid Atlantic
Keiretsu Forum Mid Atlantic investment in Series A - iQure Pharma
National Institutes of Health
National Institutes of Health investment in Grant - iQure Pharma
Keiretsu Forum Northwest
Keiretsu Forum Northwest investment in Series A - iQure Pharma
Keiretsu Forum
Keiretsu Forum investment in Series A - iQure Pharma
Beat Widler
Beat Widler investment in Convertible Note - iQure Pharma
Official Site Inspections
http://www.iqurepharma.com
- Host name: server230.campusspeicher.de
- IP address: 91.203.110.196
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "iQure Pharma"
Team - iqurepharma.com
Management team. Pawel Zolnierczyk Co-founder & Chief Executive Officer; Henk de Wilde Chief Operating Officer and R&D Director; Dr. Art Wamil, MD Chief Medical OfficerSee details»
iQure Pharma Inc. | LinkedIn
IQure Pharma Inc. is a biotech company focused on developing new treatments for neurodegenerative diseases. Last month, they announced their latest round of funding: $4 …See details»
iQure Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new …See details»
iQure Pharma - Craft
IQure Pharma has 5 employees across 2 locations and $1.2 m in total funding,. See insights on iQure Pharma including office locations, competitors, revenue, financials, executives, …See details»
iQure Pharma - Overview, News & Similar companies - ZoomInfo
Www.iqurepharma.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. iQure Pharma Secures Funding from Ventura BioMed Investors a... Oct 23, …See details»
iQurePharma - VentureRadar
Sep 1, 2020 iQurePharma Follow Following Location: USA. Founded in 2019. Privately Held. Develops therapeutics for neuropathic pain, epilepsy, and neurodegenerative diseases, …See details»
Iqure Pharma Company Profile -Sales, Contacts, Competitors – …
Www.iqurepharma.com: There are 554 Companies located at 251 LITTLE FALLS DR, Wilmington, DE 19808 Map View larger ... which also operates under the name Iqure, is located in …See details»
iQure Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for iQure Pharma. Use the PitchBook Platform to explore the full profile.See details»
iQure Pharma
At iQure Pharma, we are a dedicated team of scientists, clinicians, and innovators united by a shared mission: to restore glutamate balance and break the cycle of excitotoxicity in …See details»
iQure Pharma Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for iQure Pharma Inc. of Wilmington, DE. Get the latest business insights from Dun & Bradstreet.See details»
iQure Pharma Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore iQure Pharma Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, …See details»
iQure Pharma Inc. Information - RocketReach
Iqurepharma.com; View Similar People. Related Companies Orthobond LLC. 13 $12m ARDVRK Technologies. 5 $6m Cardinal Partners (CP) 3 $1m Klinexa Inc. 4 $27.1m Inside Edge …See details»
iQure Pharma Targets Future with New Board Appointments
Life Sciences industry experts Michael D. Webb and Brian Cain bring extensive expertise in strategic pharmaceutical growth DELAWARE, April 07, 2022 ─iQure Pharma Inc. (iQure), a …See details»
Pipeline - iqurepharma.com
IQ-007 breaks the excitotoxic cycle by restoring glutamate balance - and thereby breaks the seizure cycle in epilepsy. It enhances glutamate uptake 2.5-fold, counteracting the toxic …See details»
iQurePharma | VentureRadar
Website: https://iqurepharma.com/ Develops therapeutics for neuropathic pain, epilepsy, and neurodegenerative diseases, advancing preclinical development of novel ...See details»
iQure Pharma Inc. Overview | SignalHire Company Profile
WHO WE ARE iQure Pharma is uniquely positioned in developing new therapeutics solutions by bridging inventions stemming mostly from academia research with pharma industry, founded …See details»
iQure Pharma Inc. Announces Dr. Katrin Rupalla as the newest …
Recent posts. March 12, 2025 iQure Pharma Receives Approval for iQ-007 Phase 1 First in Human Study; January 23, 2025 iQure Pharma’s iQ-007 Receives FDA Orphan Drug …See details»
Contact - iqurepharma.com
I agree to the processing of my personal data contained in the above form for the purpose of answering my enquiry. Privacy policy and Terms & conditons.See details»
iQure Pharma Inc. Secures $4 Million in Funding to Revolutionize ...
Jan 7, 2025 iQure Pharma Inc., a pioneering biotechnology firm focused on bridging academia’s cutting-edge research with the pharmaceutical industry, has successfully raised $4 million in …See details»
News - iQure Pharma
Jun 20, 2024 March 12, 2025 iQure Pharma Receives Approval for iQ-007 Phase 1 First in Human StudySee details»